Skip to main content

Table 1 Patient and disease characteristics

From: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio

Age  
   31–80 (Mean: 59)  
Sex  
   17 female 23 male  
Disease n
   Colorectal cancer 15
   Hepatocellular carcinoma 5
   Neuroendocrine tumors 10
   Breast cancer 4
   Lung cancer 2
   Endometrial cancer 1
   Ovarian cancer 1
   Unknown primary 2